Predicting viral load suppression by self-reported adherence, pharmacy refill counts and real time medication monitoring among people living with HIV in Tanzania.

"Declarations Ethics approval and consent to participateThe study was approved by the Kilimanjaro Christian Medical College Research Ethics and Review Committee (CRERC) and the National Health Research Ethics Sub-Committee (NathRec) of Tanzania. Written informed consent was requested from study participants before enrolment. Competing interestsThe authors declare that they have no competing interests. All authors have read and approved the final manuscript. Competing interests The authors declare that they have no competing interests. All authors have read and approved the final manuscript."

"Funding We thank European and Developing Countries Clinical Trials Partnership (EDCTP) for their financial support of this study (Grant No. TMA972)."

"We conducted a post-hoc analysis of part of the data from the randomized controlled REMIND-HIV trial, in which PLHIV had been randomly allocated to (1) RTMM, (2) Short Message Service (SMS) reminder texts or (3) standard of care and followed for 48 weeks. Details of the trial have been described elsewhere []. The study was approved by the College Research and Ethical Review Committee (CRERC) of Kilimanjaro Christian Medical University College (KCMUCo) and the National Health Research Ethics Sub-Committee (NatHREC) of the National Medical Research Institute (NIMR) of Tanzania. The trial was registered at the Pan African Clinical Trials Registry under PACTR201712002844286."